| J Leonard Dire, MD | |
|
175 Memorial Hwy, Ste. 1-1, New Rochelle, NY 10801-5635 | |
| (914) 235-3535 | |
| (914) 235-4108 |
| Full Name | J Leonard Dire |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 38 Years |
| Location | 175 Memorial Hwy, New Rochelle, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588639389 | NPI | - | NPPES |
| 65F4221351 | Other | NY | MEDICARE |
| 01694944 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 172283 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Montefiore New Rochelle Hospital | New rochelle, NY | Hospital |
| White Plains Hospital Center | White plains, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
An accurate system for tracking the quality of colonoscopies and determining the appropriate intervals between these procedures could contribute to both better health outcomes and lower costs. Clinician-researchers from the Regenstrief Institute have created and tested such a system in the nation's first multiple institution colonoscopy quality measurement study utilizing natural language processing and report that it is as accurate but less expensive than human review.
News outlets detail the political landscape surrounding the overhaul's implementation and provide user's guides to help consumers navigate changes. Coverage also highlights health law provisions that could impact coverage for small businesses and union members, and how the law is helping drive marketplace developments.
Researchers in the United States have demonstrated the efficient aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – in a hamster model.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
› Verified 1 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
An accurate system for tracking the quality of colonoscopies and determining the appropriate intervals between these procedures could contribute to both better health outcomes and lower costs. Clinician-researchers from the Regenstrief Institute have created and tested such a system in the nation's first multiple institution colonoscopy quality measurement study utilizing natural language processing and report that it is as accurate but less expensive than human review.
News outlets detail the political landscape surrounding the overhaul's implementation and provide user's guides to help consumers navigate changes. Coverage also highlights health law provisions that could impact coverage for small businesses and union members, and how the law is helping drive marketplace developments.
Researchers in the United States have demonstrated the efficient aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – in a hamster model.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| J Leonard Dire, MD 175 Memorial Hwy, Ste. 1-1, New Rochelle, NY 10801-5635 Ph: (914) 235-3535 | J Leonard Dire, MD 175 Memorial Hwy, Ste. 1-1, New Rochelle, NY 10801-5635 Ph: (914) 235-3535 |
News Archive
An accurate system for tracking the quality of colonoscopies and determining the appropriate intervals between these procedures could contribute to both better health outcomes and lower costs. Clinician-researchers from the Regenstrief Institute have created and tested such a system in the nation's first multiple institution colonoscopy quality measurement study utilizing natural language processing and report that it is as accurate but less expensive than human review.
News outlets detail the political landscape surrounding the overhaul's implementation and provide user's guides to help consumers navigate changes. Coverage also highlights health law provisions that could impact coverage for small businesses and union members, and how the law is helping drive marketplace developments.
Researchers in the United States have demonstrated the efficient aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – in a hamster model.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.
› Verified 1 days ago
Dr. Daniel Harold Pomerantz, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16 Guion Pl, New Rochelle, NY 10801 Phone: 914-365-3615 Fax: 914-365-5453 | |
Richard Gottfried, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1296 North Ave, New Rochelle, NY 10804 Phone: 914-235-8224 Fax: 914-235-6940 | |
Dr. Michele Halpern, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16 Guion Pl, New Rochelle, NY 10801 Phone: 914-632-5000 | |
Dr. Gerald Edmund Thomson, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 85 Premium Point, New Rochelle, NY 10801 Phone: 914-633-5547 | |
Donald Scott Miller, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 20 Cedar St Fl 2, New Rochelle, NY 10801 Phone: 914-633-7870 Fax: 914-633-7626 | |
Dr. Melvyn S Bleiberg, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 80 Oxford Rd, New Rochelle, NY 10804 Phone: 914-576-6783 | |
Dr. Frank M Tamarin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 175 Memorial Hwy, Suite 3-6, New Rochelle, NY 10801 Phone: 914-235-7302 Fax: 914-636-6030 |